PubRank

Gabriele Grassi

Author PubWeight™ 28.19‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Connective tissue growth factor: a crucial cytokine-mediating cardiac fibrosis in ongoing enterovirus myocarditis. J Mol Med (Berl) 2007 1.83
2 Mathematical modelling and controlled drug delivery: matrix systems. Curr Drug Deliv 2005 1.75
3 Light regulates the cell cycle in zebrafish. Curr Biol 2003 1.55
4 Bortezomib arrests the proliferation of hepatocellular carcinoma cells HepG2 and JHH6 by differentially affecting E2F1, p21 and p27 levels. Biochimie 2008 0.96
5 Mathematical modeling of simultaneous drug release and in vivo absorption. Int J Pharm 2011 0.96
6 Inhibitory effects of fenofibrate on apoptosis and cell proliferation in human endothelial cells in high glucose. J Mol Med (Berl) 2007 0.95
7 MMP-9 microsatellite polymorphism and susceptibility to carotid arteries atherosclerosis. Arterioscler Thromb Vasc Biol 2006 0.88
8 Features of vulnerable plaques and clinical outcome of UA/NSTEMI: Relationship with matrix metalloproteinase functional polymorphisms. Atherosclerosis 2010 0.87
9 Improving siRNA bio-distribution and minimizing side effects. Curr Drug Metab 2011 0.86
10 Effects of E2F1-cyclin E1-E2 circuit down regulation in hepatocellular carcinoma cells. Dig Liver Dis 2011 0.86
11 Proliferation of human primary vascular smooth muscle cells depends on serum response factor. Eur J Cell Biol 2010 0.85
12 Serum response factor depletion affects the proliferation of the hepatocellular carcinoma cells HepG2 and JHH6. Biochimie 2010 0.85
13 Short term effects of doxycycline on matrix metalloproteinases 2 and 9. Cardiovasc Drugs Ther 2008 0.85
14 Interaction of G-rich GT oligonucleotides with nuclear-associated eEF1A is correlated with their antiproliferative effect in haematopoietic human cancer cell lines. FEBS J 2006 0.83
15 Association of interferon-gamma +874A polymorphism with reduced long-term inflammatory response in haemodialysis patients. Nephrol Dial Transplant 2006 0.83
16 Role of E2F1-cyclin E1-cyclin E2 circuit in human coronary smooth muscle cell proliferation and therapeutic potential of its downregulation by siRNAs. Mol Med 2009 0.81
17 Two-dimensional enzyme diffusion in laterally confined DNA monolayers. Nat Commun 2011 0.81
18 Alcohol reduces MMP-2 in humans and isolated smooth muscle cells. Alcohol 2008 0.80
19 Aptamers as targeting delivery devices or anti-cancer drugs for fighting tumors. Curr Drug Metab 2013 0.80
20 Liposomes as siRNA delivery vectors. Curr Drug Metab 2014 0.79
21 The impact of inflammation on metabolic regulation in chronic kidney disease: a review. J Ren Nutr 2005 0.79
22 Physical characterization of alginate-Pluronic F127 gel for endoluminal NABDs delivery. Soft Matter 2014 0.79
23 Overexpression of the elongation factor 1A1 relates to muscle proteolysis and proapoptotic p66(ShcA) gene transcription in hypercatabolic trauma patients. Metabolism 2007 0.78
24 Oral anticoagulation and VKORC1 polymorphism in patients with a mechanical heart prosthesis: a 6-year follow-up. J Thromb Thrombolysis 2012 0.78
25 Targeting of protease 2A genome by single and multiple siRNAs as a strategy to impair CVB3 life cycle in permissive HeLa cells. Methods Find Exp Clin Pharmacol 2009 0.78
26 Novel design of drug delivery in stented arteries: a numerical comparative study. Math Biosci Eng 2009 0.77
27 Decreased IL-10 mRNA expression in patients with advanced renal failure undergoing conservative treatment. Cytokine 2007 0.77
28 Prostate-tumor-inducing gene-1 analysis in human prostate cancer cells and tissue in relation to Mycoplasma infection. Cancer Invest 2008 0.77
29 Vascular sources of oxidative stress: implications for uremia-related cardiovascular disease. J Ren Nutr 2007 0.77
30 Epigenetic and miRNAs Dysregulation in Prostate Cancer: The role of Nutraceuticals. Anticancer Agents Med Chem 2016 0.75
31 The more basic isoform of eEF1A relates to tumour cell phenotype and is modulated by hyper-proliferative/differentiating stimuli in normal lymphocytes and CCRF-CEM T-lymphoblasts. Hematol Oncol 2012 0.75
32 Structural characterization of calcium alginate matrices by means of mechanical and release tests. Molecules 2009 0.75
33 Reduction of melting temperature and enthalpy of drug crystals: theoretical aspects. Eur J Pharm Sci 2013 0.75
34 Improving drug efficacy and specificity by innovative drug delivery approaches. Curr Med Chem 2013 0.75
35 Chemical Engineering in the "BIO" world. Curr Drug Deliv 2016 0.75
36 Application of mathematical modeling in sustained release delivery systems. Expert Opin Drug Deliv 2014 0.75
37 Effects of various promoter derived sequences on the cleavage kinetic of an hammerhead ribozyme directed against cyclin E1 mRNA. Drug Metab Lett 2007 0.75